ISRG Healthcare
Intuitive Surgical
| P/E Trailing | -- |
| P/E Forward | -- |
| PEG Ratio | -- |
| Market Cap | -- |
| Price Target | -- |
| D/E Ratio | -- |
| Current Ratio | -- |
| Cash | -- |
| Total Debt | -- |
| Net Cash | -- |
| Gross Margin | -- |
| Operating Margin | -- |
| Net Margin | -- |
| ROE | -- |
| FCF | -- |
| GF Score | -- |
| Altman Z-Score | -- |
| Piotroski F-Score | -- |
| Div. Yield | -- |
| Analyst Rating | -- |
STRONG SELL: Metrics within normal ranges.
Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Thursday, January 22, including President Trump's meeting with European Union (EU) leadership; corporate earnings results …
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
Why Intuitive Surgical is on investors’ radar today Intuitive Surgical (ISRG) continues to draw attention after recent share price moves, with the stock down around 1% over the past day …
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting earnings this Thursday after the bell. Here’s what you need to know.
ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.
Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? …
Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De …
All three of these healthcare giants are leaders in their niches.
Intuitive Surgical Stock Slides as 2026 Guidance Trails Expectations